Express Pharma

US FDA issues Form-483 with eight observations to Lupin’s drug, API production facilities in Mandideep plant

The US Food and Drug Administration (FDA) had inspected the Mandideep Unit-1 facility in Madhya Pradesh from 14th November, 2022, to 23rd November, 2022

0 486